glp 1 cardiac benefits The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1 Receptor Agonists in Heart
Description
10.1007/s10735-010-9304-4 43 KassemS.KhalailaB.SteinN.SalibaW.ZainaA
PLoS ONE 13(3):e0193473 Strazzullo P, DElia L, Kandala N-B, Cappuccio FP (2009) Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies
As researcher Anton Pottegard explained to Medscape Medical News, 'This makes the results quite valuable, as they provide reassurance that the recent concern does not seem to be supported by data'
It's been open to the public since 2016
Most available data are derived from studies with small sample sizes and limited follow-up periods
